Company: APM
Filing Date: 2025-07-15
Form Type: DRS
Source: 0001213900-25-063906
Chunk: 20

Company: Aptorum Group Ltd
Filing Date: 2025-07-15
Form: DRS
Chunk 20
---
orum Class A ordinary shares and Aptorum Class B ordinary shares, voting as a class, present in person or represented by proxy at the Special Meeting and entitled to vote, is required to approve the Proposal No. 4. Abstentions and broker -nonvotes, if any, will have no effect on the outcome of Proposal No. 4. Q:Who counts the votes? A:Votes will be counted by the inspector of election appointed for the Special Meeting. Ian Huen, Aptorum’s CEO will serve as Aptorum’s inspector of election. Q:Why is Aptorum seeking shareholder approval to issue shares of Aptorum Delaware common stock to existing DiamiR stockholders in the Merger? A:Because Nasdaq Listing Rule 5635(a) requires shareholder approval with respect to the issuance of Aptorum securities when, among other instances, the shares to be issued are being issued in connection with the acquisition of the stock or assets of another company and are equal to 20% or more of the outstanding shares of Aptorum common stock before the issuance. In the case of the Merger, Aptorum expects to issue approximately [ ] million shares of Aptorum Delaware common stock, which will represent greater than 20% of its voting stock outstanding before the issuance. Accordingly, Aptorum is seeking shareholder approval of the issuance pursuant to the Merger under the Nasdaq rules. Q:Will the common stock of the Combined Company trade on an exchange? A:Aptorum Class A ordinary shares are currently listed on Nasdaq under the symbol “APM.” After completion of the Merger, it is expected that the common stock of the Combined Company will trade on Nasdaq under the symbol “[ ].” It is a condition to the consummation of the Merger that the common stock of the Combined Company remains trading on the Nasdaq Capital Market. If such listing condition is not met, the Merger will not be consummated unless the condition is waived. The Nasdaq condition set forth in the Merger Agreement is not expected to be waived by the applicable parties. On July [ ], 2025 the last trading day before the date of this proxy statement/prospectus, the closing sale price of Aptorum Class A ordinary shares was $[ ] per share. Q:Who will be the directors of the Combined Company following the Merger? A:Immediately following the Merger, the Combined Company board of directors will be composed of five (5) members, two (2) of whom have been designated by Diami